Research

We discover personalized medical solutions for environmentally triggered diseases.

Translation: Where Medical Research Reaches People

How can we bring new scientific insights to patients more quickly? At Helmholtz Munich, we work hand in hand with leading…

Nurse and patient in hospital bed with medical monitors

How Foundation Models Are Shaping Biomedical Research

AI-powered foundation models like GPT have evolved from everyday tools for simple tasks to powerful systems capable of…

An AI powered system automating remote patient monitoring by analyzing real time health data and vital signs, futuristic AI-driven healthcare platform_AdobeStock_1366228679

Science Through an Artistic Lens

In a world where scientific innovation is increasingly interconnected, the RepliFate-Artist in Residence program seeks to…

Artist in Residence Programme_Cellular Reprogramming Necklace by Anna Dumitriu photo credit Audrey Rose Mizzi large_QUER

Tracing the First Building Blocks of Life

What connects Helmholtz Munich with space research? The globally unique analytical methods developed by Prof. Philippe…

Bennu polycam mosaic obtained before spacecraft arrival

Ali Ertürk’s Journey in Transformative Biomedical Imaging

Imagine a world where the most intricate networks and processes within whole bodies are visible – down to the level of…

Ferroptosis: Controlling Life or Death of Cells

Cell death is indispensable to life, as it ensures the removal of damaged or unnecessary cells. Among the many ways a cell can…

Germany’s Largest Biorepository

The largest repository of human biosamples in Germany is located at the Helmholtz Munich campus. It features cutting-edge…

Nako Eröffnung 2018; weltweit größten Stickstofftanks für Gesundheitsproben

The "farm effect" can protect against allergies, asthma, and hay fever.

An international research team has identified for the first time which bacteria in barn air are responsible for the "farm effect" that can protect against allergies, asthma, and hay fever.

A daily routine for children with type 1 diabetes: monitoring blood glucose.

Research fully realizes its value where it reaches people – when findings translate into new treatment options from which those affected can benefit. How this can be achieved in practice for type 1 diabetes is demonstrated by the Institute of…

Arzt mit Stethoskop und geöffneten Händen. Über den Händen schwebt eine schematische Grafik der Lunge. Daneben verschiedene Icons zu medizinischen Leistungen

Helmholtz Munich and Khumbu are collaborating on a new research program led by Prof. Ali Önder Yildirim, Director of the Institute of Lung Health and Immunity at Helmholtz Munich. The collaboration aims to develop a novel therapeutic approach for…

A new interdisciplinary team at Helmholtz Munich aims to bridge one of healthcare AI's longstanding challenges: translating promising algorithms into tools that perform reliably in clinical practice. The M1 Clinical AI Consultants, based at the…

Using advanced intravital microscopy, Helmholtz Munich researchers have been able to observe early immune reactions in the living lung in real time. The images show that specific T cells are activated within hours after contact with components of…

Dr. Robert Frömel and Dr. Hossam Montaser have been awarded Marie Skłodowska Curie Postdoctoral Fellowships. Over a period of two years, the EU funded fellowships will support their independent research projects on gene regulation in brain…

Cover of the Pixi book from Carlsen, which describes type 1 diabetes.

The new Pixi Wissen book, “Finn and the Sleepover – Type 1 Diabetes at School”, demonstrates how research can be translated into practical resources for everyday life. Together with partners, Helmholtz Munich has developed a scientifically grounded,…

A close-up visualization of the CRISPR Cas9 mechanism at work, showcasing the intricate molecular interactions involved in gene editing.

A research team led by Prof. Stefan Stricker at Helmholtz Munich and Ludwig Maximilian University has developed TAPIR, a CRISPR-based technology that enables precise control of protein production in cells. The method provides new insights into the…

Dr. Steffen Schneider of Helmholtz Munich and KI macht Schule gGmbH has been admitted as a new member of the Young Academy. Working at the interface of artificial intelligence, neuroscience, and statistical modelling, Schneider joins the Academy's…

Microscopic view of glioblastoma tumor cells

Helmholtz Munich, together with the University of Münster and ITM Isotope Technologies Munich SE (ITM), has reported updated preliminary results from a Phase 1 clinical trial evaluating ITM-31, a targeted radiotherapy for glioblastoma. The treatment…

Prof. Heiko Lickert has been awarded an ERC Proof of Concept (PoC) Grant from the European Research Council (ERC). The funding is intended to advance a novel regenerative therapeutic approach for type 2 diabetes from basic research into clinical…

From 5 to 8 July 2026, Munich’s Muffatwerk will become a unique space where the worlds of scientific research and artistic creation converge. The exhibition “In Formation” brings together four international artists – Anna Dumitriu, Solveig Lill,…

A major international distinction for Leipzig-based obesity research: Prof. Antje Körner has been awarded the Willendorf Award by the World Obesity Federation.

Prof. Vasilis Ntziachristos has been awarded the Future Insight Prize 2026 by Merck. The prize recognizes his pioneering contributions to non-invasive health sensing and is endowed with a research grant of €300,000.

When Cytoskeletal Proteins Act in the Cell Nucleus

The cytoskeleton gives cells their shape and helps them move. Researchers at Helmholtz Munich and the Ludwig Maximilian University now show that, in neural stem cells, proteins of the cytoskeleton are also found in the cell nucleus, where they can…

FGF21 is primarily known as a metabolic hormone. A new study by researchers at Helmholtz Munich and the Ludwig Maximilians University has now described a previously unknown mechanism through which FGF21 supports cells under protein folding stress:…

Researchers at Helmholtz Munich, together with international partners, have developed an ultrathin sensor patch capable of non-invasively monitoring key health parameters in preterm infants. The silk-based patch measures temperature, pH, sodium, and…

Prof. Fabian Theis has been awarded the Akademiepreis of the Berlin-Brandenburg Academy of Sciences and Humanities. The Academy honors his pioneering work in computational biomedicine and the development of novel methods for biomedical data analysis.…

Helmholtz Munich and Vector Institute Strengthen International AI Research Collaboration

Helmholtz Munich and the Vector Institute have signed a Memorandum of Understanding (MOU) to strengthen international collaboration in artificial intelligence (AI) and machine learning. The agreement establishes a formal framework for joint research,…

Prof. Marcus Conrad has been elected a member of the German National Academy of Sciences Leopoldina. With this prestigious scientific honor, the Academy recognizes his outstanding contributions to the study of regulated cell death and its…

Core facilities support and enable our center’s research by providing centralized access to cutting-edge technologies, instruments and highly skilled staff, fostering innovation and connecting scientists across disciplines.

Find out more

Artificial Intelligence in Healthcare - New AI Applications in Medicine

Our cutting-edge research forms the basis for medical innovations. Together with our partners, we are accelerating the transfer of our research to bring new ideas from the laboratories to application even faster.
n addition to implementing innovative diagnostics, medical technologies, sustainable prevention measures and personalized therapeutics, we are shaping a dialogical and interactive transfer of knowledge. In this way, we make a valuable contribution to a healthier society.

More information

Vascular and glomeruli details of the human kidney.

Eleftheria Zeggini

"We discover breakthrough solutions for better health in a rapidly changing world."

to Eleftheria's page

Prof. Dr. Eleftheria Zeggini

Program Director ENABLE

Stephan Herzig

"It is my vision to successfully drive a mechanistic finding into clinical application in the area of obesity-related metabolic dysfunction as well as cancer cachexia."

to Stephan's page

Prof. Dr. Stephan Herzig

Director of the Diabetes Center, Scientific Director

Martin Hrabě de Angelis

"Leading science means guiding discovery toward public good – with excellence, integrity, and impact."

to Martin's page

Porträt Martin Hrabe de Angelis
Querformat
Background: Office / Indoorplant

Prof. Dr. Dr. h.c. Martin Hrabě de Angelis

Member and Spokesperson of the Executive Board (acting), Director of the Institute of Experimental Genetics, Scientific Director

Fabian Theis

"With AI we can imagine a future where diagnosing and treating diseases is more affordable, widely available, and thus more democratic."

to Fabian's page

Prof. Dr. Fabian Theis

Director of the Computational Health Center

Vasilis Ntziachristos

"Our research at Helmholtz Munich is driven by our interest to provide solutions that address critical unmet medical need and positively impact healthcare and the well-being of society."

Prof. Dr. Vasilis Ntziachristos

Director of the Bioengineering Center

Erika von Mutius

"I am a passionate pediatrician scientist. My research focusses on the roots of asthma and allergy development with the aim of ultimately preventing these diseases in children at risk."

freigestelltes Porträtbild für Kontakte auf der Website

Prof. Dr. Erika von Mutius

Director of the Environmental Health Center

Magdalena Götz

"My vision is to explore the mechanisms of neurogenesis to use it for instructing neurogenesis for replacement of lost neurons."

Prof. Dr. Magdalena Götz

Director of the Stem Cell Center

Michael Sattler

"We combine integrative structural biology to elucidate molecular mechanisms of biological pathways, highlighting the essential roles of dynamics and transient regulatory interations to enable innovative structure-based drug discovery."

to Michael´s page

Prof. Dr. Michael Sattler

Director of the Molecular Targets & Therapeutics Center

We collaborate with a dynamic network of regional and international partners. Together, we engage in impactful projects and cooperations that shape the future of medicine.
Read more

Blue and white sphere network structure - abstract design connection design - 3D illustration

On This Page

Translation: Where Medical Research Reaches People

How Foundation Models Are Shaping Biomedical Research

Science Through an Artistic Lens

Tracing the First Building Blocks of Life

Ali Ertürk’s Journey in Transformative Biomedical Imaging

Ferroptosis: Controlling Life or Death of Cells

Germany’s Largest Biorepository

Immune System: The Farm Effect – Clearer Than Ever

From the Lab to the Patient: Four Clinical Trials on Type 1 Diabetes

Helmholtz Munich and Khumbu Start Joint Program on COPD

Helmholtz Munich Launches M1 Clinical AI Consultants to Bring AI Research to Patient Care

SARS-CoV-2: Real-time Imaging Reveals Unexpectedly Fast Immune Response in the Lung

Two MSCA Postdoctoral Fellowships Awarded to Researchers at Helmholtz Munich

Pixi Wissen Book: Type 1 Diabetes at School

New CRISPR Method Makes It Possible to Control Protein Production in Cells

Steffen Schneider Admitted to the Young Academy

Helmholtz Munich and Partners Report Phase 1 Results for Targeted Glioblastoma Therapy

Heiko Lickert Receives ERC Proof of Concept Grant for Diabetes Research

“In Formation”: Helmholtz Munich Brings Science as Art to Muffatwerk

Antje Körner Receives Prestigious International Award for Research on Childhood Obesity

Vasilis Ntziachristos Receives Future Insight Prize 2026

When Cytoskeletal Proteins Act in the Cell Nucleus

FGF21 Helps Cells Cope with Protein Folding Stress

Helmholtz Munich and Partners Develop AI-Powered Sensor Patch for Neonatal Care

Fabian Theis Receives Akademiepreis of the Berlin-Brandenburg Academy of Sciences and Humanities

Helmholtz Munich and Vector Institute Strengthen International AI Research Collaboration

Marcus Conrad Elected to the Leopoldina